SCHEMBL5038713

SCHEMBL5038713

CC[C@H](NCCCC(=O)NCc1ccccc1)C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.57
EPHX2 P34913 6/20 0.57
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
FAAH O00519 3/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C19 P33261 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA4 P22748 1/20 0.49
CA5A P35218 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
LMNA P02545 2/20 0.49
CNR1 P21554 2/20 0.48
CNR2 P34972 2/20 0.48
TRPV1 Q8NER1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19450068 0.80 POLB (0.51) POLB
SCHEMBL5034461 0.79 FAAH (0.46) EPHX2FAAH
SCHEMBL5043991 0.79 ALDH1A1 (0.47) EPHX2MEN1KMT2ACYP3A4CYP2C19
SCHEMBL5037670 0.76 NOD1 (0.47) EPHX2MEN1KMT2AFAAHCNR1
SCHEMBL14186683 0.76 NOD1 (0.47) EPHX2MEN1KMT2AFAAHCNR1
SCHEMBL27703735 0.76 MEN1 (0.83) GAAEPHX2MEN1KMT2AFAAH
SCHEMBL4401015 0.76 EPHX2 (0.87) GAAEPHX2MEN1KMT2AFAAH
SCHEMBL2942358 0.75 MEN1 (0.96) GAAEPHX2MEN1KMT2AFAAH
SCHEMBL1516109 0.74 EPHX2 (0.97) GAAEPHX2MEN1KMT2AFAAH
SCHEMBL10963930 0.74 GAA (0.77) GAAEPHX2MEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1339669-B1 N-ALKYLATED GABA COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS UCB PHARMA SA (BE) 2008-06-04 EP disclosed
US-7112612-B2 N-alkylated GABA compounds, processes for their preparation and their use as medicaments UCB S.A. (BE) 2006-09-26 US disclosed